PART1 and breast cancer: Since the androgen induction response (although significant) is minimal in TNBC cells (Figure 1I), and that there is no connection between androgen signaling and PART1 in breast cancer patient tumors (Figure S1), we opted to not use charcoal-stripped FBS and phenol red-free media for the functional assays.